Skip Navigation

Cardiovascular Research 1995 30(1):87-96; doi:10.1016/S0008-6363(95)00009-7
© 1995 by European Society of Cardiology
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Groves, P. H.
Right arrow Articles by Lewis, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Groves, P. H.
Right arrow Articles by Lewis, M. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1995, European Society of Cardiology

The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty

Peter H. Groves*, Adrian P. Banning, William J. Penny, Andrew C. Newby, Hilary A. Cheadlea and Malcolm J. Lewisb

aDepartment of Cardiology, University of Wales College of Medicine, Heath Park, Cardiff CF4 4XN, UK
bDepartment of Pharmacology and Therapeutics, University of Wales College of Medicine, Heath Park, Cardiff CF4 4XN, UK

* Corresponding author: Department of Cardiology, Royal Brompton National Heart and Lung Hospital, Sydney St, London SW3 6NP, UK Tel. 071 3528121; Fax: 071 3528629.

Objectives: Nitric oxide reduces platelet adhesion and platelet-thrombus formation following angioplasty and inhibits smooth muscle cell (SMC) proliferation in vitro. In this study we investigated the effects of the nitric oxide donor molsidomine on SMC proliferation and intimal growth following experimental angioplasty. Methods: Bilateral carotid angioplasty was performed in 24 anesthetized pigs. Animals were randomized to receive oral molsidomine (whose active metabolite is SIN-1; 0.3 mg/kg every 8 h; n = 12) or placebo (n = 12) for 48 h before angioplasty and until the arteries were removed either 7 or 21 days (n = 12 each group) later. SMC proliferation was quantified by immunocytochemical staining with an antibody to the proliferating cell nuclear antigen (PCNA) and morphometric changes by computerized planimetry. SMC's were identified by {alpha}-actin staining. Results: After 3 weeks treatment with molsidomine there was a significant prolongation in bleeding time [mean ± SEM](151 ± 6 to 187 ± 7 s. P < 0.01) and a sustained increase in arterial wall cyclic GMP (6.57 ± 1.29 to 13.24 ± 1.02 pmol/mg protein, P < 0.05). Molsidomine significantly reduced intimal proliferation when compared with placebo in arteries with an intact internal elastic lamina at 7 days (4.3 ± 0.7 vs. 9.6 ± 1.9 PCNA index, P < 0.005) and medial proliferation at 7 days (2.4 ± 0.2 vs. 4.2 ± 0.7 PCNA index, P < 0.05) and at 21 days (1.3 ± 0.1 vs. 1.9 ± 0.2 PCNA index, P < 0.05) after angioplasty. In arteries with rupture of the internal elastic lamina, intimal and medial SMC proliferation were similar in molsidomine- and placebo-treated animals. Intimal cell number and intimal area were uninfluenced by treatment with molsidomine in either the presence or absence of rupture of the internal elastic lamina. Conclusions: These results show for the first time that exogenous nitric oxide inhibits SMC proliferation following balloon angioplasty in vivo. The antiproliferative effects of nitric oxide are overwhelmed when injury is severe and are not associated with a reduction in intimal thickening. The inhibitory effects of nitric oxide on platelet adhesion and SMC proliferation identify a possible role for high local concentrations of nitric oxide to modify the vascular response to balloon angioplasty.

KEYWORDS Restenosis; SIN-1; Platelets; Molsidomine; Smooth muscle cell proliferation; Pig, arteries


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
D. L. Tharp, I. Masseau, J. Ivey, V. K. Ganjam, and D. K. Bowles
Endogenous testosterone attenuates neointima formation after moderate coronary balloon injury in male swine
Cardiovasc Res, April 1, 2009; 82(1): 152 - 160.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Y. Jeremy, D. Rowe, A. M. Emsley, and A. C. Newby
Nitric oxide and the proliferation of vascular smooth muscle cells
Cardiovasc Res, August 15, 1999; 43(3): 580 - 594.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Kibbe, T. Billiar, and E. Tzeng
Inducible nitric oxide synthase and vascular injury
Cardiovasc Res, August 15, 1999; 43(3): 650 - 657.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Greenlees, R. M Wadsworth, P. A Martorana, and C. L Wainwright
The effects of L-arginine on neointimal formation and vascular function following balloon injury in heritable hyperlipidaemic rabbits
Cardiovasc Res, August 1, 1997; 35(2): 351 - 359.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.